Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Goodwill & Intangibles (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Goodwill & Intangibles for 16 consecutive years, with $194.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Goodwill & Intangibles fell 51.18% year-over-year to $194.9 million, compared with a TTM value of $194.9 million through Dec 2025, down 51.18%, and an annual FY2025 reading of $194.9 million, down 51.18% over the prior year.
  • Goodwill & Intangibles was $194.9 million for Q4 2025 at Orthofix Medical, down from $270.6 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $399.3 million in Q4 2024 and bottomed at $118.8 million in Q3 2022.
  • Average Goodwill & Intangibles over 5 years is $234.9 million, with a median of $272.2 million recorded in 2025.
  • The sharpest move saw Goodwill & Intangibles surged 167.38% in 2023, then crashed 51.18% in 2025.
  • Year by year, Goodwill & Intangibles stood at $124.0 million in 2021, then skyrocketed by 58.22% to $196.2 million in 2022, then surged by 59.27% to $312.4 million in 2023, then increased by 27.81% to $399.3 million in 2024, then plummeted by 51.18% to $194.9 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for OFIX at $194.9 million in Q4 2025, $270.6 million in Q3 2025, and $273.8 million in Q2 2025.